Tidal Investments’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.09M Buy
75,832
+14,056
+23% +$1.7M 0.01% 773
2026
Q1
$9.7M Buy
61,776
+40,466
+190% +$6.22M 0.02% 568
2025
Q4
$3.71M Buy
21,310
+10,512
+97% +$1.92M 0.01% 747
2025
Q3
$1.56M Buy
10,798
+6,763
+168% +$829K ﹤0.01% 1017
2025
Q2
$406K Buy
4,035
+1,189
+42% +$90.9K ﹤0.01% 1530
2025
Q1
$217K Buy
+2,846
New +$218K ﹤0.01% 1662
2024
Q4
Sell
-24,102
Closed -$1.76M 1923
2024
Q3
$1.76M Buy
24,102
+19,696
+447% +$1.45M 0.02% 721
2024
Q2
$295K Buy
+4,406
New +$171K ﹤0.01% 1543
2022
Q2
Sell
-34,194
Closed -$804K 1141
2022
Q1
$804K Buy
+34,194
New +$794K 0.02% 492

Other funds holding INSM

Tidal Investments's INSM Position: Q2 2026 in Review

Tidal Investments increased its Insmed (INSM) stake by 23% in Q2 2026, buying an estimated $1.7M and bringing the position to 75,832 shares worth $8.09M. The position accounts for 0.01% of the portfolio, ranked #773.

Tidal Investments first reported a position in INSM in Q1 2022 and has held it in 9 quarters since. The position peaked at $9.7M in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Tidal Investments held 75,832 shares of Insmed worth $8.09M as of Q2 2026.
  • Tidal Investments bought 14,056 Insmed shares in Q2 2026, an estimated $1.7M.
  • Insmed made up 0.01% of Tidal Investments's portfolio in Q2 2026, its #773 holding.
  • Tidal Investments first reported a position in Insmed in Q1 2022 and has held it in 9 quarters since.
  • Tidal Investments's Insmed position peaked at $9.7M in Q1 2026.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.